Macromolecules (proteins/peptides) have the potential for the development of new
therapeutics. Due to their specific mechanism of action, macromolecules can be …

This review highlights the recent developments in the area of nanocarrier‐based targeted
delivery systems for both conventional drugs and therapeutic agents of increased …

Recent advances in biotechnology demonstrate that peptides and proteins are the basis of a
new generation of drugs. However, the transportation of protein drugs in the body is limited …

This review highlights the recent developments in the area of nanocarrier-based mucosal
delivery of therapeutic biomolecules and antigens. Macromolecular drugs have the unique …

Protein/antibody therapeutics have exhibited the advantages of high specificity and activity
even at an extremely low concentration compared to small molecule drugs. However, they …

The advent of recombinant DNA technology and computational designing has fueled the
emergence of proteins and peptides as a new class of modern therapeutics such as …

In recent years, peptides have emerged as a distinct class of therapeutic agents due to their
unique intrinsic advantages, as well as scientific and technological progress that has helped …

Nanobiotechnology, involving biological systems manufactured at the molecular level, is a
multidisciplinary field that has fostered the development of nanoscaled pharmaceutical …

There has been growing discovery and use of therapeutic peptides in drug delivery and
tissue engineering. Peptides are smaller than proteins and can be formulated into drug …

During the past two decades, the clinical use of biopharmaceutical products has markedly
increased because of their obvious advantages over conventional small-molecule drug …